BioSpace News Archive

SIME Completes Study Validating Clinical AI Platform in Neonatal Respiratory Care

Data demonstrating that AI accurately predicts Respiratory Distress Syndrome (RDS) in premature babies, enables company to accelerate product development and begin next phase clinical studies in Europe, the US and China

May 6, 2019
·
2 min read
Drug Development

Safety and Efficacy Data From the MIV-711 Phase II Open Label Extension Study Presented at the OARSI World Congress

Medivir AB informs that new data from the phase II program of MIV-711, has been presented as a poster during the Osteoarthritis Research Society International world congress.

May 6, 2019
·
3 min read
Policy

Does your Dog Have Itchy Ears?

Does your dog shake their head frequently, scratch incessantly at their ears or have smelly, dirty or itchy ears? In dogs, allergies can appear as ear infections and can be recurrent and hard to get rid of.

May 6, 2019
·
2 min read
Business

Dubai Science Park Signs Partnership Agreement With US Venture Capital Firm 1792 Partners to Attract American Science Companies to Dubai

Agreement Signed During High-level Business Mission to California led by Dubai Investment Development Agency, Dubai Exports

May 6, 2019
·
5 min read
Job Trends

Recursion Releases Open-Source Data from Largest Ever Dataset of Biological Images, Inviting Data Science Community to Develop New and Improved Machine Learning Algorithms for the Life Sciences Industry

Clinical-stage biotech offering unique access to cell biology images with the goal of driving more effective artificial intelligence methods in drug discovery and development

May 6, 2019
·
5 min read
Business

Trividia Health, Inc. Announces Launch of TRUE A-G Scan™

Trividia Health Inc. announced today the launch of the TRUE A-G Scan™. The new product was presented this past week at NACDS Annual in Palm Beach, FL.

May 6, 2019
·
2 min read
Biotech Beach

FDB Launches Unified Global Brand Identity

Refreshed global brand unveiled across all digital and social media channels marking the company’s fourth decade of continuous business operations

May 6, 2019
·
3 min read
Business

Innovus Pharmaceuticals Reports Preliminary Q1 2019 Sales Revenue of Approximately $5.4 million

Preliminary Quarterly Revenue Increase of 12.8% Comparable to 2018 Fourth Quarter and Increase of 18.0% Comparable to 2018 First Quarter

May 6, 2019
·
3 min read
Drug Development

SpringWorks Therapeutics Announces Initiation of Phase 1b Clinical Trial of MEK Inhibitor PD-0325901 in Combination with BeiGene’s RAF Dimer Inhibitor Lifirafenib in Advanced or Refractory Solid Tumors

SpringWorks Therapeutics, Inc. announced that the first patient has been dosed in a Phase 1b study to evaluate the combination of SpringWorks Therapeutics’ investigational MEK inhibitor, PD-0325901, and BeiGene, Ltd.’s investigational RAF dimer inhibitor, lifirafenib, in patients with advanced or refractory solid tumors.

May 6, 2019
·
6 min read
Policy

AAN 2019: Pooled Analyses of Two Emgality® (galcanezumab-gnlm) Phase 3 Studies Show Reduction in Monthly Migraine Headache Days in Low- and High-Frequency Episodic Migraine Subgroups

Eli Lilly and Company announced the upcoming presentation of results from pooled subgroup analyses of efficacy data from the Phase 3 EVOLVE-1 and EVOLVE-2 studies.

May 6, 2019
·
7 min read